Roles of mitochondria in the hallmarks of metastasis

AD Scheid, TC Beadnell, DR Welch - British Journal of Cancer, 2021 - nature.com
Although mitochondrial contributions to cancer have been recognised for approximately a
century, given that mitochondrial DNA (mtDNA) is dwarfed by the size of the nuclear genome …

Autophagy, anoikis, ferroptosis, necroptosis, and endoplasmic reticulum stress: Potential applications in melanoma therapy

M Ashrafizadeh, R Mohammadinejad… - Journal of cellular …, 2019 - Wiley Online Library
Melanoma as the most major skin malignancy has attracted much attention, so far. Although
a successful therapeutic strategy requires an accurate understanding of the precise …

Syndecan-4 as a pathogenesis factor and therapeutic target in cancer

JOS Onyeisi, CC Lopes, M Götte - Biomolecules, 2021 - mdpi.com
Cancer is an important cause of morbidity and mortality worldwide. Advances in research on
the biology of cancer revealed alterations in several key pathways underlying tumorigenesis …

Role of phytochemicals in perturbation of redox homeostasis in cancer

S Gaikwad, SK Srivastava - Antioxidants, 2021 - mdpi.com
Over the past few decades, research on reactive oxygen species (ROS) has revealed their
critical role in the initiation and progression of cancer by virtue of various transcription …

Glycolysis-related lncRNA TMEM105 upregulates LDHA to facilitate breast cancer liver metastasis via sponging miR-1208

J Han, X Chen, J Wang, B Liu - Cell Death & Disease, 2023 - nature.com
Increased glycolysis is one of the key metabolic hallmarks of cancer cells. However, the
roles of lncRNAs in energy metabolism and cancer metastasis remain unclear. Here, the …

[HTML][HTML] Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway

T Li, T Guo, H Liu, H Jiang, Y Wang - Oncology reports, 2021 - spandidos-publications.com
Platelet‑derived growth factor (PDGF) is a potent mitogen and chemoattractant that serves a
role in the development of several types of solid cancer, and abnormal PDGF activity has …

Atovaquone suppresses triple-negative breast tumor growth by reducing immune-suppressive cells

N Gupta, S Gaikwad, I Kaushik, SE Wright… - International Journal of …, 2021 - mdpi.com
A major contributing factor in triple-negative breast cancer progression is its ability to evade
immune surveillance. One mechanism for this immunosuppression is through ribosomal …

lncRNA APOC1P1-3 promoting anoikis-resistance of breast cancer cells

Q Lu, L Wang, Y Gao, P Zhu, L Li, X Wang, Y **… - Cancer Cell …, 2021 - Springer
Background Anoikis resistance plays a critical role in the tumor metastasis by allowing
survival of cancer cells in the systemic circulation. We previously showed that long non …

Penfluridol overcomes paclitaxel resistance in metastatic breast cancer

N Gupta, P Gupta, SK Srivastava - Scientific reports, 2019 - nature.com
Paclitaxel is a first line chemotherapeutic agent for the patients with metastatic breast
cancer. But inherited or acquired resistance to paclitaxel leads to poor response rates in a …

[HTML][HTML] Advances in understanding the role and mechanisms of tumor stem cells in HER2-positive breast cancer treatment resistance

L Xu, F Han, L Zhu, W Ding… - International …, 2023 - spandidos-publications.com
Abstract Approximately 15-20% of breast carcinomas exhibit human epidermal growth factor
receptor (HER2) protein overexpression. HER2-positive breast cancer (BC) is a …